Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis

Published:2021-11-23 Issue:1 Volume:42 Page:34-44
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Eum Seenae¹^ORCID,Sayre Franklin²,Lee Adam M.³,Stingl Julia C.⁴,Bishop Jeffrey R.³⁵

Affiliation:

1. Department of Pharmacogenomics School of Pharmacy Shenandoah University Fairfax Virginia USA

2. Librarian Department Thompson Rivers University Kamloops British Columbia Canada

3. Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis Minnesota USA

4. Institute of Clinical Pharmacology University Hospital of RWTH Aachen Aachen Germany

5. Department of Psychiatry and Behavioral Sciences Medical School University of Minnesota Minneapolis Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2644

Reference50 articles.

1. The Management of Major Depressive Disorder Working Group Management.VA/DoD clinical practice guideline for the management of major depressive disorder.2016.

2. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment

3. Agency for Healthcare Research and Quality (AHRQ) Rockville. Medical Expenditure Panel Survey (MEPS) 2008‐2018.

4. FDAFDA approved drug products. Available from:http://www.accessdata.fda.gov/scripts/cder/drugsatfda/[Accessed August 2 2021].

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genetic landscape of substance use disorders;Molecular Psychiatry;2024-05-29

2. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion;Drug Metabolism and Disposition;2024-03-11

3. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration;Clinical Pharmacokinetics;2024-02-29

4. Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall;Medicina;2023-01-06

5. Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers;Journal of Pharmacology and Experimental Therapeutics;2022-07-07